Catalyst Biosciences Inc (CBIO)
NASDAQ:CBIO

Catalyst Biosciences (CBIO) Stock Investors

745 Followers
Based on 610,515 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold CBIO
On average, investors allocate 2.31% of their portfolios to CBIO
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 610,515 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding CBIO

0.9%
Last 7
Days
4.1%
Last 30
Days
Percentages indicate the change in the number of portfolios holding CBIO, out of 610,515 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

CBIO Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Reduced
<0.01%
$0.25
Based on the activity of 11,659 investors who made their portfolios public
The table shows changes in CBIO in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

CBIO Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
General Electric
5.80%
-0.11%
+2.22%
$89.98B
Industrial Goods
Tilray
4.82%
-0.13%
-0.86%
$1.96B
Basic Materials
Syros Pharmaceuticals
3.88%
-0.65%
-4.28%
$99.71M
Healthcare
Gilead Sciences
4.37%
-0.29%
-0.72%
$108.32B
Healthcare
Crispr Therapeutics AG
3.97%
-0.01%
-0.53%
$4.35B
Healthcare
Canopy Growth
4.38%
-0.17%
-2.66%
$1.45B
Basic Materials
Moderna
6.08%
+0.24%
+1.51%
$65.41B
Healthcare
Nikola
5.08%
-0.75%
-1.04%
$1.35B
Consumer Goods
Bristol Myers
4.08%
+0.31%
+0.81%
$158.46B
Healthcare
QuantumScape
3.70%
-0.12%
-0.70%
$4.08B
Industrial Goods
Based on the activity of 610,515 active portfolios
Open your Smart Portfolio

CBIO Investor Analysis

CBIO investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
8.9%
of CBIO holders
are under 35
Average Segment Performance
Average P/E Ratio1.83
Beta4.80
Dividend Yield5.23%
CBIO investors between 35–55

Between 35–55

8.2%
Last 30 days
Holdings Change
64.2%
of CBIO holders
are between 35–55
Average Segment Performance
Average P/E Ratio0.49
Beta1.09
Dividend Yield5.04%
CBIO investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
26.8%
of CBIO holders
are over 55
Average Segment Performance
Average P/E Ratio0.75
Beta1.00
Dividend Yield4.33%
Overview of age group and performance of CBIO stock investors
See who invests in CBIO according to age group and performance.

FAQ

How many retail Investors hold CBIO?
<0.1% of TipRank’s retail investors hold CBIO in their portfolios.
    What is CBIO Investor Sentiment?
    CBIO’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of CBIO in the last 7 days?
      ▼ 0.9% of TipRank’s retail investors changed their holding of CBIO in the last 7 days.
        What percentage of retail investors changed their holding of CBIO in the last 30 days?
        ▼ 4.1% of TipRank’s retail investors changed their holding of CBIO in the last 30 days.
          What is the average age of retail investors who hold CBIO?
          The average age of CBIO Holders is between 35–55.
            What other stocks have CBIO investors also bought?
            CBIO Investors also bought GE, TLRY, SYRS, GILD, CRSP, CGC, MRNA, NKLA, BMY, QS.

              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              AAgilent
              ALGNAlign Tech
              ALNYAlnylam Pharma
              AMRNAmarin
              BAXBaxter International

              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis